Kaiseraugst (Switzerland), Maastricht (Netherlands), April 30 , 2024
dsm-firmenich today announces that, as part of its share repurchase program to cover share plans as announced on April 8, 2024, during the period from April 22, 2024 up to and including April 26, 2024 a total number of 452,835 shares have been repurchased on its behalf.
As part of an equity forward arrangement totaling 1,000,000 shares, the shares were repurchased at an average price of €104.66 for a total amount of EUR 47.4 million.
For more detailed information, see ‘Daily transaction details Share Repurchase Program announced April 8, 2024 – Equity Forward’.
The forward transaction is expected to be finalized in May 2024, and dsm-firmenich expects to take delivery of the shares in 2025.
For more information, please contact:
dsm-firmenich media enquiries: media@dsm-firmenich.com
dsm-firmenich investor relations enquiries: investors@dsm-firmenich.com
About dsm-firmenich:
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
